Real-time
Euronext Paris
04:55:31 2024-05-02 am EDT
|
5-day change
|
1st Jan Change
|
57.52
EUR
|
-0.14%
|
|
-6.62%
|
-2.48%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
8,834
|
13,091
|
20,893
|
12,900
|
11,336
|
11,108
|
-
|
-
|
Enterprise Value (EV)
1 |
12,079
|
15,333
|
23,132
|
15,739
|
11,336
|
14,328
|
14,300
|
13,918
|
P/E ratio
|
47.2
x
|
25
x
|
27.8
x
|
22.2
x
|
45.4
x
|
28
x
|
20.6
x
|
18.2
x
|
Yield
|
0.7%
|
0.99%
|
0.92%
|
1.49%
|
-
|
1%
|
1.36%
|
1.5%
|
Capitalization / Revenue
|
1.94
x
|
2.41
x
|
3.11
x
|
1.92
x
|
1.74
x
|
1.57
x
|
1.46
x
|
1.36
x
|
EV / Revenue
|
2.65
x
|
2.82
x
|
3.44
x
|
2.34
x
|
1.74
x
|
2.03
x
|
1.88
x
|
1.71
x
|
EV / EBITDA
|
13
x
|
10.9
x
|
12.2
x
|
10.4
x
|
8.31
x
|
9.57
x
|
8.6
x
|
7.59
x
|
EV / FCF
|
46.8
x
|
17.6
x
|
22.8
x
|
23.2
x
|
-
|
25.6
x
|
19.8
x
|
17.4
x
|
FCF Yield
|
2.14%
|
5.69%
|
4.39%
|
4.3%
|
-
|
3.91%
|
5.06%
|
5.76%
|
Price to Book
|
3.11
x
|
3.55
x
|
4.49
x
|
2.7
x
|
-
|
2.11
x
|
2.02
x
|
1.84
x
|
Nbr of stocks (in thousands)
|
178,759
|
190,749
|
192,035
|
192,365
|
192,194
|
192,855
|
-
|
-
|
Reference price
2 |
49.42
|
68.63
|
108.8
|
67.06
|
58.98
|
57.60
|
57.60
|
57.60
|
Announcement Date
|
3/4/20
|
3/1/21
|
2/22/22
|
3/1/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
4,563
|
5,439
|
6,718
|
6,712
|
6,515
|
7,056
|
7,596
|
8,157
|
EBITDA
1 |
930.7
|
1,413
|
1,902
|
1,513
|
1,364
|
1,497
|
1,662
|
1,833
|
EBIT
1 |
573.5
|
1,024
|
1,473
|
1,037
|
842
|
917.2
|
1,045
|
1,181
|
Operating Margin
|
12.57%
|
18.82%
|
21.93%
|
15.45%
|
12.92%
|
13%
|
13.76%
|
14.48%
|
Earnings before Tax (EBT)
1 |
271.5
|
694.4
|
1,057
|
780
|
423
|
568
|
740.2
|
832.7
|
Net income
1 |
195.2
|
539.4
|
783
|
606
|
310
|
397.1
|
557.4
|
615.4
|
Net margin
|
4.28%
|
9.92%
|
11.66%
|
9.03%
|
4.76%
|
5.63%
|
7.34%
|
7.54%
|
EPS
2 |
1.047
|
2.750
|
3.910
|
3.020
|
1.300
|
2.054
|
2.794
|
3.159
|
Free Cash Flow
1 |
258
|
873.2
|
1,015
|
677
|
-
|
560.6
|
723.2
|
801.8
|
FCF margin
|
5.65%
|
16.05%
|
15.11%
|
10.09%
|
-
|
7.95%
|
9.52%
|
9.83%
|
FCF Conversion (EBITDA)
|
27.72%
|
61.81%
|
53.36%
|
44.75%
|
-
|
37.46%
|
43.52%
|
43.74%
|
FCF Conversion (Net income)
|
132.17%
|
161.88%
|
129.63%
|
111.72%
|
-
|
141.18%
|
129.76%
|
130.29%
|
Dividend per Share
2 |
0.3450
|
0.6800
|
1.000
|
1.000
|
-
|
0.5733
|
0.7821
|
0.8627
|
Announcement Date
|
3/4/20
|
3/1/21
|
2/22/22
|
3/1/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019 S2
|
2020 S1
|
2020 S2
|
2021 S1
|
2021 Q3
|
2021 Q4
|
2021 S2
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 S2
|
2023 Q1
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2023 S2
|
2024 Q1
|
2024 S1
|
2024 S2
|
2025 S1
|
2025 S2
|
---|
Net sales
1 |
2,395
|
2,323
|
3,116
|
3,272
|
1,630
|
1,816
|
3,446
|
1,760
|
1,652
|
3,412
|
1,622
|
3,300
|
1,574
|
3,209
|
1,611
|
1,695
|
3,306
|
1,653
|
3,483
|
3,650
|
3,741
|
3,880
|
EBITDA
|
515.8
|
493
|
919.7
|
1,008
|
-
|
-
|
894
|
-
|
-
|
829
|
-
|
-
|
-
|
640
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
322.7
|
310.7
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
397
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
13.47%
|
13.37%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
12.37%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
220
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
152
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
4.74%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.7600
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/4/20
|
8/6/20
|
3/1/21
|
8/5/21
|
10/21/21
|
2/22/22
|
2/22/22
|
4/21/22
|
7/27/22
|
7/27/22
|
10/18/22
|
3/1/23
|
4/26/23
|
7/26/23
|
10/24/23
|
2/27/24
|
2/27/24
|
4/24/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
3,245
|
2,242
|
2,239
|
2,839
|
-
|
3,219
|
3,192
|
2,809
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.486
x
|
1.587
x
|
1.177
x
|
1.876
x
|
-
|
2.151
x
|
1.92
x
|
1.533
x
|
Free Cash Flow
1 |
258
|
873
|
1,015
|
677
|
-
|
561
|
723
|
802
|
ROE (net income / shareholders' equity)
|
7.09%
|
16.5%
|
18.8%
|
12.9%
|
-
|
10.7%
|
11.4%
|
12.3%
|
ROA (Net income/ Total Assets)
|
2.6%
|
6.58%
|
8.74%
|
6.24%
|
-
|
3.42%
|
4.53%
|
5.46%
|
Assets
1 |
7,514
|
8,199
|
8,954
|
9,708
|
-
|
11,606
|
12,291
|
11,280
|
Book Value Per Share
2 |
15.90
|
19.30
|
24.20
|
24.80
|
-
|
27.30
|
28.50
|
31.30
|
Cash Flow per Share
2 |
3.640
|
6.250
|
7.510
|
5.710
|
-
|
5.820
|
6.330
|
7.190
|
Capex
1 |
420
|
350
|
495
|
645
|
-
|
597
|
622
|
670
|
Capex / Sales
|
9.2%
|
6.44%
|
7.37%
|
9.61%
|
-
|
8.47%
|
8.19%
|
8.21%
|
Announcement Date
|
3/4/20
|
3/1/21
|
2/22/22
|
3/1/23
|
2/27/24
|
-
|
-
|
-
|
Last Close Price
57.6
EUR Average target price
60.88
EUR Spread / Average Target +5.69% Consensus |
1st Jan change
|
Capi.
|
---|
| -2.03% | 11.86B | | -28.69% | 70.69B | | +14.32% | 81.84B | | +9.37% | 29.03B | | -11.43% | 16.97B | | +0.71% | 16.83B | | -0.24% | 15.28B | | +6.06% | 12.41B | | +33.40% | 12.26B | | -31.23% | 11.83B |
Other Healthcare Facilities & Services
|